The lag time in initiating clinical testing of new drugs in combination with radiation therapy, a significant barrier to progress?

BACKGROUND: The clinical development of new drugs with radiation appears to be limited. We hypothesised that phase I clinical trials with radiation therapy (RT) are initiated too late into a new drug's lifetime, impeding the ability to complete RT–drug development programmes before patent expir...

Descripción completa

Detalles Bibliográficos
Autores principales: Blumenfeld, P, Pfeffer, R M, Symon, Z, Den, R B, Dicker, A P, Raben, D, Lawrence, Y R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183859/
https://www.ncbi.nlm.nih.gov/pubmed/25117813
http://dx.doi.org/10.1038/bjc.2014.448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183859/
https://www.ncbi.nlm.nih.gov/pubmed/25117813
http://dx.doi.org/10.1038/bjc.2014.448

Ejemplares similares